A 2014 study found that the presence of anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibodies represented a risk factor for central nervous system infections of C. gattii but not C. neoformans, suggesting that previously unrecognized immune system defects may contribute to disease susceptibility (10). The gene discussed is CSF2; the disease is central nervous system infectious disorder.